Skip to main content
Clinical Trials/NCT04395586
NCT04395586WithdrawnNot Applicable

Clinical Presentations, Microbiology, Antibiotic Resistance Patterns and Management Outcomes of Culture-proven Infection Among Adolescent and Adult in A Tertiary Hospital in Saudi Arabia

Aseer Central Hospital0 sitesStarted: July 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Primary Endpoint
Mortality

Study Overview

Brief Summary

The characteristics of patients as well as microbiologic profile of culture-proven infection will be studies in conjunction with clinical outcome within 28-days

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
13 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Any individual aged ≥13 year old requested for him/her bacterial/fungal culture.
  • Able to provide a written informed consent.

Exclusion Criteria

  • Age <13 years old.
  • Unable/unwilling to provide a written informed consent.

Outcomes

Primary Outcomes

Mortality

Time Frame: 28 days

All-cause and disease specific mortality

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Aseer Central Hospital
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Abdullah M. Algarni

Family medicine senior registrar

Aseer Central Hospital

Similar Trials

Clinical Presentations, Microbiology,... | Clinical Trial